Publication | Open Access

Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer

Cancer ResearchBreast OncologyMammary Gland DevelopmentEndocrine-related CancerErα-positive Mammary PreneoplasiaMedicineHormonal ReceptorMammary GlandCancer Cell BiologyBreast CancerRadiation OncologyCancer BiologyCell BiologyCell SignalingCell DevelopmentTumor BiologyPathways Collaborates